These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34309550)

  • 1. Differential Expression of Ki-67 and P27 in Cholesteatoma Compared to Skin Tissue Predicts the Prognosis of Adult Acquired Cholesteatoma.
    Türkili S; Görür K; İsmi O; Serinsöz Linke E; Vayısoğlu Y; Özcan C
    J Int Adv Otol; 2021 Jul; 17(4):306-312. PubMed ID: 34309550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
    Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
    Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma.
    Bayazít YA; Karakök M; Uçak R; Kanlíkama M
    Laryngoscope; 2001 Jun; 111(6):1037-41. PubMed ID: 11404617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.
    Araz Server E; Kalaycık Ertugay Ç; Baykal Koca S; Longur ES; Yiğit Ö; Demirhan H; Çakır Y
    J Int Adv Otol; 2019 Apr; 15(1):38-42. PubMed ID: 30541725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired middle ear cholesteatoma in children with cleft palate: experience from 18 surgical cases.
    Vincenti V; Marra F; Bertoldi B; Tonni D; Saccardi MS; Bacciu S; Pasanisi E
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):918-22. PubMed ID: 24690221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.
    Hamed MA; Nakata S; Shiogama K; Suzuki K; Sayed RH; Nishimura Y; Iwata N; Sakurai K; Badawy BS; Inada KI; Tsuge H; Tsutsumi Y
    Clin Exp Otorhinolaryngol; 2017 Sep; 10(3):213-220. PubMed ID: 28073243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of middle ear cholesteatoma in children with Turner syndrome: a multicenter experience.
    Zanetti D; Di Lella F; Negri M; Vincenti V
    Acta Biomed; 2018 Oct; 89(3):382-388. PubMed ID: 30333463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canal wall down mastoidectomy with obliteration versus canal wall up mastoidectomy in primary cholesteatoma surgery.
    Wilkie MD; Chudek D; Webb CJ; Panarese A; Banhegyi G
    J Laryngol Otol; 2019 Dec; 133(12):1074-1078. PubMed ID: 31735175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
    Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
    BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of diffusion-weighted magnetic resonance imaging in differentiation of recurrent cholesteatoma and granulation tissue after intact canal wall mastoidectomy.
    Allam HS; Abdel Razek AAK; Ashraf B; Khalek M
    J Laryngol Otol; 2019 Dec; 133(12):1083-1086. PubMed ID: 31735177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
    Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
    J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of middle ear aeration on surgical outcome after intact canal wall tympanoplasty for cholesteatoma.
    Motegi M; Yamamoto Y; Ouchi K; Akutsu T; Tada T; Kurihara S; Takahashi M; Sampei S; Sano H; Morino T; Komori M; Yamamoto K; Sakurai Y; Kojima H
    Auris Nasus Larynx; 2020 Dec; 47(6):965-975. PubMed ID: 32646631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
    Sikka K; Sharma SC; Thakar A; Dattagupta S
    J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.